Association of genetic polymorphisms in CYP1A1 and NAT2 with susceptibility to renal cancer: A case control study
10.3724/SP.J.1008.2008.01147
- Author:
Guo-Ping WANG
1
Author Information
1. Department of Epidemiology
- Publication Type:Journal Article
- Keywords:
Cytochrome P-450 1A1;
Genetic susceptibility;
N-acetyltransferase-2;
Polymorphism;
Renal cancer
- From:
Academic Journal of Second Military Medical University
2010;29(10):1147-1152
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To study the effect of genetic polymorphisms of cytochrome P4501A1 (CYP1A1), N-acetyltransferase 2 (NAT2) on the susceptibility to renal cancer. Methods: The genetic polymorphisms of CYP1A1 and NAT2 were examined in the renal cancer patients and controls using restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) methods. Results: The distribution of CYP1A1 (W/M) and NAT2 (intermediate) genotypes was significantly different between the renal cancer patients and controls (P<0.05). Individuals carrying CYP1A1 (W/M) or NAT2 (intermediate) genotypes had an increased risk for renal cancer(OR=2.487, 95% CI: 1.493-4. 142; OR=1.970, 95% CI: 1.128-3.442,respectively). Multivariate analysis showed increased risk for renal cancer patients carrying CYP1A1 (W/M) or NAT2 (intermediate) genotypes and those who smoke. Conclusion: The genotypes CYP1A1 (W/M) and NAT2 (intermediate) are the risk factors of renal cancer, and the 2 genotypes have a interactive effect and both have a joint effect with smoking.
